At the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, Hélio Tomás, PhD, senior research associate at the Instituto de Biologia Experimental e ...

The technology is designed to simplify the bio-separation process while reducing manufacturing costs.

Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.

The company is establishing commercial production capabilities to fuel plans to launch autologous CAR T cell therapies in ...

Eveo Cell Therapy Platform enables automated, multi-parallel intensified production of autologous cell therapies Compact ...

Sartorius has collaborated with ElevateBio, a cell therapy CDMO, among other partners, to test the Eveo platform.

ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...

Whether for drug screening or toxicity testing, stem cell-based 3D tissue models are key to biomedical research. However, producing cell aggregates in bioreactors is highly complex and cost-intensive.

What is the current status of cell therapies today? It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the ...

LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...

Shares of ImmunityBio IBRX rose more than 7% on Friday after the company announced that it completed two manufacturing ...